What are the Global Growth Factors?
Factors such as process miniaturization, high demand for lab automation equipment in drug discovery and clinical diagnostics, higher reproducibility and accuracy, and large workforce demand and supply gap are likely to drive the growth of Lab Automation Market. In addition, lab automation offers enhanced productivity and reduced costs, better personnel safety, and small volumes of samples and reagents.
What The Experts Says about the Market Growth?
The global lab automation market is expected to reach $5.20 Billion by 2022 from USD 4.06 Billion in 2017, at a CAGR of 5.1%.
Browse and in-depth TOC on “Lab Automation Market”
279 – Tables
31 – Figures
235 – Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html
The automated workstations segment to account for the largest market share in 2017
Based on equipment and software, the market is segmented into automated workstations, off-the-shelf workcells, robotic systems, automated storage and retrieval system, software, and other equipment. In 2017, the automated workstations segment is expected to account for the largest share of the lab automation market. The high demand for automation in liquid handling is the key factor driving market growth in this segment. Automated workstations offer advantages such as enhanced accuracy, and reduced time and cost.
The genomics solutions segment to grow at the highest CAGR
Based on applications, the lab automation market is segmented into drug discovery, clinical diagnostics, genomics solutions, proteomics solutions, microbiology, and other applications. The genomics solutions segment is expected to grow at the highest CAGR during the forecast period. The use of automation is on the rise in genomics for high-throughput requirements, providing greater reproducibility and throughput as compared to manual methods.
Download PDF Brochure:
North America is expected to command the largest share of the global lab automation market in 2017. The increasing adoption of lab automation systems, implementation of the Affordable Care Act (ACA) in 2010 and economy stimulus programs such as increased funds for the National Institutes of Health (NIH) and the National Science Foundation (NSF), and increased R&D activities by biotechnology and pharmaceutical companies are driving growth in the lab automation market in North America.
Key Market Players:
In 2017, Tecan (Switzerland) is expected to dominate the lab automation market. Some of the other players competing in this market are PerkinElmer (US), Danaher (Beckman Coulter & Molecular Devices) (US), Thermo Fisher (US), Agilent Technologies (US), Hamilton Robotics (US), Abbot Diagnostics (US), Eppendorf (Germany), QIAGEN (Netherlands), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany).
Request Sample Report:
Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic Labs) – Global Forecast to 2022